List of Tables
Table 1. Global Allergy Treatment Loratadine Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global Allergy Treatment Loratadine Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global Allergy Treatment Loratadine Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global Allergy Treatment Loratadine Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Allergy Treatment Loratadine Revenue by Region (2026-2031) & (US$ Million)
Table 6. Global Allergy Treatment Loratadine Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (K Units)
Table 7. Global Allergy Treatment Loratadine Sales by Region (2020-2025) & (K Units)
Table 8. Global Allergy Treatment Loratadine Sales by Region (2026-2031) & (K Units)
Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 10. Global Allergy Treatment Loratadine Sales by Manufacturers (2020-2025) & (K Units)
Table 11. Global Allergy Treatment Loratadine Sales Share by Manufacturers (2020-2025)
Table 12. Global Allergy Treatment Loratadine Revenue by Manufacturers (2020-2025) & (US$ Million)
Table 13. Global Allergy Treatment Loratadine Revenue Market Share by Manufacturers (2020-2025)
Table 14. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 15. Global Allergy Treatment Loratadine by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Allergy Treatment Loratadine as of 2024)
Table 16. Global Allergy Treatment Loratadine Average Gross Margin (%) by Manufacturer (2020 VS 2024)
Table 17. Global Allergy Treatment Loratadine Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/Unit)
Table 18. Key Manufacturers Allergy Treatment Loratadine Manufacturing Base and Headquarters
Table 19. Global Allergy Treatment Loratadine Market Concentration Ratio (CR5 and HHI)
Table 20. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 21. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 22. Global Allergy Treatment Loratadine Sales by Type (2020-2025) & (K Units)
Table 23. Global Allergy Treatment Loratadine Sales by Type (2026-2031) & (K Units)
Table 24. Global Allergy Treatment Loratadine Revenue by Type (2020-2025) & (US$ Million)
Table 25. Global Allergy Treatment Loratadine Revenue by Type (2026-2031) & (US$ Million)
Table 26. Global Allergy Treatment Loratadine ASP by Type (2020-2031) & (US$/Unit)
Table 27. Technical Specifications by Key Product Type
Table 28. Global Allergy Treatment Loratadine Sales by Application (2020-2025) & (K Units)
Table 29. Global Allergy Treatment Loratadine Sales by Application (2026-2031) & (K Units)
Table 30. Allergy Treatment Loratadine High-Growth Sectors Demand CAGR (2024-2031)
Table 31. Global Allergy Treatment Loratadine Revenue by Application (2020-2025) & (US$ Million)
Table 32. Global Allergy Treatment Loratadine Revenue by Application (2026-2031) & (US$ Million)
Table 33. Global Allergy Treatment Loratadine ASP by Application (2020-2031) & (US$/Unit)
Table 34. Top Customers by Region
Table 35. Top Customers by Application
Table 36. North America Allergy Treatment Loratadine Growth Accelerators and Market Barriers
Table 37. North America Allergy Treatment Loratadine Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 38. North America Allergy Treatment Loratadine Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 39. Europe Allergy Treatment Loratadine Growth Accelerators and Market Barriers
Table 40. Europe Allergy Treatment Loratadine Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Europe Allergy Treatment Loratadine Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 42. Asia-Pacific Allergy Treatment Loratadine Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 43. Asia-Pacific Allergy Treatment Loratadine Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 44. Asia-Pacific Allergy Treatment Loratadine Growth Accelerators and Market Barriers
Table 45. Southeast Asia Allergy Treatment Loratadine Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Central and South America Allergy Treatment Loratadine Investment Opportunities and Key Challenges
Table 47. Central and South America Allergy Treatment Loratadine Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 48. Middle East and Africa Allergy Treatment Loratadine Investment Opportunities and Key Challenges
Table 49. Middle East and Africa Allergy Treatment Loratadine Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 50. Merck Corporation Information
Table 51. Merck Description and Major Businesses
Table 52. Merck Product Models, Descriptions and Specifications
Table 53. Merck Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 54. Merck Sales Value Proportion by Product in 2024
Table 55. Merck Sales Value Proportion by Application in 2024
Table 56. Merck Sales Value Proportion by Geographic Area in 2024
Table 57. Merck Allergy Treatment Loratadine SWOT Analysis
Table 58. Merck Recent Developments
Table 59. Cadila Pharmaceuticals Corporation Information
Table 60. Cadila Pharmaceuticals Description and Major Businesses
Table 61. Cadila Pharmaceuticals Product Models, Descriptions and Specifications
Table 62. Cadila Pharmaceuticals Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 63. Cadila Pharmaceuticals Sales Value Proportion by Product in 2024
Table 64. Cadila Pharmaceuticals Sales Value Proportion by Application in 2024
Table 65. Cadila Pharmaceuticals Sales Value Proportion by Geographic Area in 2024
Table 66. Cadila Pharmaceuticals Allergy Treatment Loratadine SWOT Analysis
Table 67. Cadila Pharmaceuticals Recent Developments
Table 68. Morepen Corporation Information
Table 69. Morepen Description and Major Businesses
Table 70. Morepen Product Models, Descriptions and Specifications
Table 71. Morepen Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 72. Morepen Sales Value Proportion by Product in 2024
Table 73. Morepen Sales Value Proportion by Application in 2024
Table 74. Morepen Sales Value Proportion by Geographic Area in 2024
Table 75. Morepen Allergy Treatment Loratadine SWOT Analysis
Table 76. Morepen Recent Developments
Table 77. Ultratech India Corporation Information
Table 78. Ultratech India Description and Major Businesses
Table 79. Ultratech India Product Models, Descriptions and Specifications
Table 80. Ultratech India Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 81. Ultratech India Sales Value Proportion by Product in 2024
Table 82. Ultratech India Sales Value Proportion by Application in 2024
Table 83. Ultratech India Sales Value Proportion by Geographic Area in 2024
Table 84. Ultratech India Allergy Treatment Loratadine SWOT Analysis
Table 85. Ultratech India Recent Developments
Table 86. Vasudha Pharma Chem Corporation Information
Table 87. Vasudha Pharma Chem Description and Major Businesses
Table 88. Vasudha Pharma Chem Product Models, Descriptions and Specifications
Table 89. Vasudha Pharma Chem Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 90. Vasudha Pharma Chem Sales Value Proportion by Product in 2024
Table 91. Vasudha Pharma Chem Sales Value Proportion by Application in 2024
Table 92. Vasudha Pharma Chem Sales Value Proportion by Geographic Area in 2024
Table 93. Vasudha Pharma Chem Allergy Treatment Loratadine SWOT Analysis
Table 94. Vasudha Pharma Chem Recent Developments
Table 95. Hetero Drugs Corporation Information
Table 96. Hetero Drugs Description and Major Businesses
Table 97. Hetero Drugs Product Models, Descriptions and Specifications
Table 98. Hetero Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 99. Hetero Drugs Recent Developments
Table 100. Mylan Corporation Information
Table 101. Mylan Description and Major Businesses
Table 102. Mylan Product Models, Descriptions and Specifications
Table 103. Mylan Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 104. Mylan Recent Developments
Table 105. Changzhou Yabang Corporation Information
Table 106. Changzhou Yabang Description and Major Businesses
Table 107. Changzhou Yabang Product Models, Descriptions and Specifications
Table 108. Changzhou Yabang Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 109. Changzhou Yabang Recent Developments
Table 110. Shaanxi Hanjiang Corporation Information
Table 111. Shaanxi Hanjiang Description and Major Businesses
Table 112. Shaanxi Hanjiang Product Models, Descriptions and Specifications
Table 113. Shaanxi Hanjiang Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 114. Shaanxi Hanjiang Recent Developments
Table 115. Inke, S.A. Corporation Information
Table 116. Inke, S.A. Description and Major Businesses
Table 117. Inke, S.A. Product Models, Descriptions and Specifications
Table 118. Inke, S.A. Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 119. Inke, S.A. Recent Developments
Table 120. Argon Drugs Corporation Information
Table 121. Argon Drugs Description and Major Businesses
Table 122. Argon Drugs Product Models, Descriptions and Specifications
Table 123. Argon Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 124. Argon Drugs Recent Developments
Table 125. Key Raw Materials Distribution
Table 126. Raw Materials Key Suppliers
Table 127. Critical Raw Material Supplier Concentration (2024) & Risk Index
Table 128. Milestones in Production Technology Evolution
Table 129. Distributors List
Table 130. Market Trends and Market Evolution
Table 131. Market Drivers and Opportunities
Table 132. Market Challenges, Risks, and Restraints
Table 133. Research Programs/Design for This Report
Table 134. Key Data Information from Secondary Sources
Table 135. Key Data Information from Primary Sources
List of Figures
Figure 1. Allergy Treatment Loratadine Product Picture
Figure 2. Global Allergy Treatment Loratadine Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. USP Standards Grade Product Picture
Figure 4. EP Standards Grade Product Picture
Figure 5. Pharmaceutical Standards Grade Product Picture
Figure 6. Others Product Picture
Figure 7. Global Allergy Treatment Loratadine Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 8. Loratadine Tablet
Figure 9. Loratadine Capsules
Figure 10. Loratadine Syrup
Figure 11. Others
Figure 12. Allergy Treatment Loratadine Report Years Considered
Figure 13. Global Allergy Treatment Loratadine Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Allergy Treatment Loratadine Revenue (2020-2031) & (US$ Million)
Figure 15. Global Allergy Treatment Loratadine Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 16. Global Allergy Treatment Loratadine Revenue Market Share by Region (2020-2031)
Figure 17. Global Allergy Treatment Loratadine Sales (2020-2031) & (K Units)
Figure 18. Global Allergy Treatment Loratadine Sales (CAGR) by Region (2020-2031) (K Units)
Figure 19. Global Allergy Treatment Loratadine Sales Market Share by Region (2020-2031)
Figure 20. Top 5 and Top 10 Manufacturers Allergy Treatment Loratadine Sales Volume Market Share in 2024
Figure 21. Global Allergy Treatment Loratadine Revenue Market Share Ranking (2024)
Figure 22. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 23. USP Standards Grade Revenue Market Share by Manufacturer in 2024
Figure 24. EP Standards Grade Revenue Market Share by Manufacturer in 2024
Figure 25. Pharmaceutical Standards Grade Revenue Market Share by Manufacturer in 2024
Figure 26. Others Revenue Market Share by Manufacturer in 2024
Figure 27. Global Allergy Treatment Loratadine Sales Market Share by Type (2020-2031)
Figure 28. Global Allergy Treatment Loratadine Revenue Market Share by Type (2020-2031)
Figure 29. Global Allergy Treatment Loratadine Sales Market Share by Application (2020-2031)
Figure 30. Global Allergy Treatment Loratadine Revenue Market Share by Application (2020-2031)
Figure 31. North America Allergy Treatment Loratadine Sales YoY (2020-2031) & (K Units)
Figure 32. North America Allergy Treatment Loratadine Revenue YoY (2020-2031) & (US$ Million)
Figure 33. North America Top 5 Manufacturers Allergy Treatment Loratadine Sales Revenue (US$ Million) in 2024
Figure 34. North America Allergy Treatment Loratadine Sales Volume (K Units) by Type (2020- 2031)
Figure 35. North America Allergy Treatment Loratadine Sales Revenue (US$ Million) by Type (2020 - 2031)
Figure 36. North America Allergy Treatment Loratadine Sales Volume (K Units) by Application (2020-2031)
Figure 37. North America Allergy Treatment Loratadine Sales Revenue (US$ Million) by Application (2020-2031)
Figure 38. US Allergy Treatment Loratadine Revenue (2020-2031) & (US$ Million)
Figure 39. Canada Allergy Treatment Loratadine Revenue (2020-2031) & (US$ Million)
Figure 40. Mexico Allergy Treatment Loratadine Revenue (2020-2031) & (US$ Million)
Figure 41. Europe Allergy Treatment Loratadine Sales YoY (2020-2031) & (K Units)
Figure 42. Europe Allergy Treatment Loratadine Revenue YoY (2020-2031) & (US$ Million)
Figure 43. Europe Top 5 Manufacturers Allergy Treatment Loratadine Sales Revenue (US$ Million) in 2024
Figure 44. Europe Allergy Treatment Loratadine Sales Volume (K Units) by Type (2020-2031)
Figure 45. Europe Allergy Treatment Loratadine Sales Revenue (US$ Million) by Type (2020-2031)
Figure 46. Europe Allergy Treatment Loratadine Sales Volume (K Units) by Application (2020-2031)
Figure 47. Europe Allergy Treatment Loratadine Sales Revenue (US$ Million) by Application (2020-2031)
Figure 48. Germany Allergy Treatment Loratadine Revenue (2020-2031) & (US$ Million)
Figure 49. France Allergy Treatment Loratadine Revenue (2020-2031) & (US$ Million)
Figure 50. U.K. Allergy Treatment Loratadine Revenue (2020-2031) & (US$ Million)
Figure 51. Italy Allergy Treatment Loratadine Revenue (2020-2031) & (US$ Million)
Figure 52. Russia Allergy Treatment Loratadine Revenue (2020-2031) & (US$ Million)
Figure 53. Asia-Pacific Allergy Treatment Loratadine Sales YoY (2020-2031) & (K Units)
Figure 54. Asia-Pacific Allergy Treatment Loratadine Revenue YoY (2020-2031) & (US$ Million)
Figure 55. Asia-Pacific Top 8 Manufacturers Allergy Treatment Loratadine Sales Revenue (US$ Million) in 2024
Figure 56. Asia-Pacific Allergy Treatment Loratadine Sales Volume (K Units) by Type (2020- 2031)
Figure 57. Asia-Pacific Allergy Treatment Loratadine Sales Revenue (US$ Million) by Type (2020- 2031)
Figure 58. Asia-Pacific Allergy Treatment Loratadine Sales Volume (K Units) by Application (2020-2031)
Figure 59. Asia-Pacific Allergy Treatment Loratadine Sales Revenue (US$ Million) by Application (2020-2031)
Figure 60. Indonesia Allergy Treatment Loratadine Revenue (2020-2031) & (US$ Million)
Figure 61. Japan Allergy Treatment Loratadine Revenue (2020-2031) & (US$ Million)
Figure 62. South Korea Allergy Treatment Loratadine Revenue (2020-2031) & (US$ Million)
Figure 63. China Taiwan Allergy Treatment Loratadine Revenue (2020-2031) & (US$ Million)
Figure 64. India Allergy Treatment Loratadine Revenue (2020-2031) & (US$ Million)
Figure 65. Central and South America Allergy Treatment Loratadine Sales YoY (2020-2031) & (K Units)
Figure 66. Central and South America Allergy Treatment Loratadine Revenue YoY (2020-2031) & (US$ Million)
Figure 67. Central and South America Top 5 Manufacturers Allergy Treatment Loratadine Sales Revenue (US$ Million) in 2024
Figure 68. Central and South America Allergy Treatment Loratadine Sales Volume (K Units) by Type (2021-2031)
Figure 69. Central and South America Allergy Treatment Loratadine Sales Revenue (US$ Million) by Type (2020-2031)
Figure 70. Central and South America Allergy Treatment Loratadine Sales Volume (K Units) by Application (2020-2031)
Figure 71. Central and South America Allergy Treatment Loratadine Sales Revenue (US$ Million) by Application (2020-2031)
Figure 72. Brazil Allergy Treatment Loratadine Revenue (2020-2025) & (US$ Million)
Figure 73. Argentina Allergy Treatment Loratadine Revenue (2020-2025) & (US$ Million)
Figure 74. Middle East, and Africa Allergy Treatment Loratadine Sales YoY (2020-2031) & (K Units)
Figure 75. Middle East and Africa Allergy Treatment Loratadine Revenue YoY (2020-2031) & (US$ Million)
Figure 76. Middle East and Africa Top 5 Manufacturers Allergy Treatment Loratadine Sales Revenue (US$ Million) in 2024
Figure 77. Middle East and Africa Allergy Treatment Loratadine Sales Volume (K Units) by Type (2021-2031)
Figure 78. South America Allergy Treatment Loratadine Sales Revenue (US$ Million) by Type (2020-2031)
Figure 79. Middle East and Africa Allergy Treatment Loratadine Sales Volume (K Units) by Application (2020-2031)
Figure 80. Middle East and Africa Allergy Treatment Loratadine Sales Revenue (US$ Million) by Application (2020-2031)
Figure 81. GCC Countries Allergy Treatment Loratadine Revenue (2020-2025) & (US$ Million)
Figure 82. Turkey Allergy Treatment Loratadine Revenue (2020-2025) & (US$ Million)
Figure 83. Egypt Allergy Treatment Loratadine Revenue (2020-2025) & (US$ Million)
Figure 84. South Africa Allergy Treatment Loratadine Revenue (2020-2025) & (US$ Million)
Figure 85. Allergy Treatment Loratadine Industry Chain Mapping
Figure 86. Regional Allergy Treatment Loratadine Manufacturing Base Distribution (%)
Figure 87. Global Allergy Treatment Loratadine Production Market Share by Region (2020-2031)
Figure 88. Allergy Treatment Loratadine Production Process
Figure 89. Regional Allergy Treatment Loratadine Production Cost Structure
Figure 90. Channels of Distribution (Direct Vs Distribution)
Figure 91. Bottom-up and Top-down Approaches for This Report
Figure 92. Data Triangulation
Figure 93. Key Executives Interviewed
